Latest news with #medicalequipment
Yahoo
a day ago
- Business
- Yahoo
Cooper Companies Second Quarter 2025 Earnings: EPS Misses Expectations
Revenue: US$1.00b (up 6.3% from 2Q 2024). Net income: US$87.7m (down 1.3% from 2Q 2024). Profit margin: 8.7% (down from 9.4% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$0.44 (down from US$0.45 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 39%. Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 13% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on Cooper Companies' balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
3 days ago
- Business
- Yahoo
ANGLE Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Revenue: UK£2.86m (up 31% from FY 2023). Net loss: UK£14.2m (loss narrowed by 29% from FY 2023). UK£0.048 loss per share (improved from UK£0.077 loss in FY 2023). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 44%. Earnings per share (EPS) exceeded analyst estimates by 14%. Looking ahead, revenue is forecast to grow 63% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Medical Equipment industry in the United Kingdom. Performance of the British Medical Equipment industry. The company's shares are down 25% from a week ago. We should say that we've discovered 6 warning signs for ANGLE (1 is a bit concerning!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Inspiration Healthcare Group Full Year 2025 Earnings: UK£0.19 loss per share (vs UK£0.088 loss in FY 2024)
Revenue: UK£38.3m (up 1.7% from FY 2024). Net loss: UK£15.0m (loss widened by 148% from FY 2024). UK£0.19 loss per share (further deteriorated from UK£0.088 loss in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Medical Equipment industry in the United Kingdom. Performance of the British Medical Equipment industry. The company's share price is broadly unchanged from a week ago. You still need to take note of risks, for example - Inspiration Healthcare Group has 4 warning signs (and 3 which are potentially serious) we think you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Reuters
4 days ago
- Business
- Reuters
EBOS Group's major shareholder Sybos launches NZ$949 million selldown, term sheet shows
SYDNEY, May 28 (Reuters) - EBOS Group's ( opens new tab, major shareholder Sybos is selling NZ$949 million ($566.74 million) worth of shares in the New Zealand-based medical equipment manufacturer, according to a term sheet by Reuters. The investor is selling 26.74 million shares at NZ$35.50 each, an 8.9% discount to the stock's closing price on Wednesday, the term sheet showed. EBOS declined to comment. The sale represents about 13.2% of EBOS stock and Sybos will retain a 4.9% holding once the block trade is complete, the term sheet showed. Investment bank UBS is leading the deal, according to the term sheet. ($1 = 1.6745 New Zealand dollars)
Reuters
5 days ago
- Business
- Reuters
Hologic rejects over $16 billion take-private proposal from TPG and Blackstone, FT reports
May 27 (Reuters) - Medical equipment maker Hologic (HOLX.O), opens new tab rejected an up to $16.7 billion non-binding offer from private equity firms TPG (TPG.O), opens new tab and Blackstone (BX.N), opens new tab, the Financial Times reported on Tuesday, citing people familiar with the matter. Shares of Hologic were up 15.1% in afternoon trading. While Hologic declined the offer, there is still a chance that the deal talks could be revived, the report added. The proposal, which could become one of the biggest leveraged buyouts of the year, would value Hologic's shares between $70 and $72, an around 30% premium to Friday's close of $54.28. Earlier this month, the Marlborough, Massachusetts-based company lowered its fiscal 2025 profit forecast, citing uncertainty around the tariffs imposed by U.S. President Donald Trump's administration. It had also warned that the demand for gantry placements, medical equipment used in medical imaging and radiation therapy, would be lower in 2025. TPG declined to comment, while Hologic and Blackstone did not immediately respond to Reuters' requests for comment.
